Hepatocellular adenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatocellular adenoma}} | {{Hepatocellular adenoma}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{ZAS}} | ||
==Overview== | ==Overview== | ||
An annual follow-up with [[Magnetic resonance imaging|MRI]] or [[ultrasound]] may be scheduled for female patients until [[menopause]]. | |||
==Hepatocellular adenoma | |||
==Secondary Prevention== | |||
== | An annual follow-up with [[Magnetic resonance imaging|MRI]] or [[ultrasound]] may be scheduled for female patients until [[menopause]], when:<ref>{{Cite journal | ||
| author = [[Maarten G. Thomeer]], [[Mirelle Broker]], [[Joanne Verheij]], [[Michael Doukas]], [[Turkan Terkivatan]], [[Diederick Bijdevaate]], [[Robert A. De Man]], [[Adriaan Moelker]] & [[Jan N. IJzermans]] | |||
| title = Hepatocellular adenoma: when and how to treat? Update of current evidence | |||
| journal = [[Therapeutic advances in gastroenterology]] | |||
| volume = 9 | |||
| issue = 6 | |||
| pages = 898–912 | |||
| year = 2016 | |||
| month = November | |||
| doi = 10.1177/1756283X16663882 | |||
| pmid = 27803743 | |||
}}</ref> | |||
* The [[adenoma]] is < 5 cm in diameter | |||
* It has [[Regression|regressed]] to < 5 cm after discontinuation of [[Oral contraceptive|oral contraceptive medications]] | |||
==References== | ==References== | ||
{{reflist|1}} | {{reflist|1}} | ||
Latest revision as of 13:10, 23 August 2019
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma secondary prevention |
|
Risk calculators and risk factors for Hepatocellular adenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
An annual follow-up with MRI or ultrasound may be scheduled for female patients until menopause.
Secondary Prevention
An annual follow-up with MRI or ultrasound may be scheduled for female patients until menopause, when:[1]
- The adenoma is < 5 cm in diameter
- It has regressed to < 5 cm after discontinuation of oral contraceptive medications
References
- ↑ Maarten G. Thomeer, Mirelle Broker, Joanne Verheij, Michael Doukas, Turkan Terkivatan, Diederick Bijdevaate, Robert A. De Man, Adriaan Moelker & Jan N. IJzermans (2016). "Hepatocellular adenoma: when and how to treat? Update of current evidence". Therapeutic advances in gastroenterology. 9 (6): 898–912. doi:10.1177/1756283X16663882. PMID 27803743. Unknown parameter
|month=ignored (help)